Donald Lohman Email and Phone Number
Strategic Chief Legal and Administrative Officer demonstrably sound in judgment with the courage to be innovative and decisive yet adaptable in fluid situations with changing priorities. Relentless when facing obstacles, unshakeable in crises, and adept at transforming ambiguity into clarity and chaos into actionable structure. Proven foresight in identifying and averting or managing existential crises. Committed to guiding growth-oriented strategies. Well prepared, steady leader who builds relationships based on trust and shared objectives with a collaborative and diplomatic approach. Problem solves utilizing critical thinking, influence, and negotiations skills. Accomplished senior executive with a strong track record in: • Formulating and managing complex legal strategies • Negotiating multifaceted, multiparty agreements • Preparing businesses to become publicly traded or transacted upon • Leading cross-functional teams and identifying and developing diverse, talented team members • Serving as a subject matter expert with multiple external stakeholders and constituents Selected Accomplishments: • Prepared $720 million business for public offering in five (5) months• Played instrumental role in executive leadership team that turned around business in under 12 months. Grew revenue +3% from -17% and operating income +21% from -66% in previous fiscal year by strategically recapturing market share, optimizing pricing and enhancing output • Won support of 50 State and Territory Attorneys General for resolution of company’s alleged opioid liability by demonstrating consistent leadership in controlled substances compliance • Negotiated a full and final release of all outstanding opioid claims through Chapter 11 bankruptcy process • Managed 3000+ cases by leading a team of ≥120 law firm attorneys/paralegals at a fraction of the costs incurred by other similarly situated defendants CONTACT DETAILS... ✉️ donlohman@outlook.com 📞 314-707-7274 AREAS OF EXPERTISE… Executive Legal Leadership | Legal Strategy | Compliance | Litigation Management | Government Affairs | Complex Negotiations | FDA & DEA Regulatory | Corporate Governance | Legal Operations | SEC | Mergers & Acquisitions | Divestitures | HIPPA | Leadership | Building Relationships | Coaching | Diversity, Equity and Inclusion | Talent Development | FTC | Enterprise Risk Management | Cybersecurity | Data Privacy | Collaborative | Influencing Others | Critical Thinking | Problem Solving | Hatch-Waxman | Cross-Functional Team Leadership
Api Innovation Center
View-
Chief Legal And Administrative Officer And Corporate SecretaryApi Innovation Center Jun 2023 - PresentSt Louis, Missouri, Us
-
Member, Board Of TrusteesUniversity Of Health Sciences And Pharmacy In St. Louis 2022 - PresentSt. Louis, Missouri, UsVice Chair, Governance CommitteeAudit Committee -
General Counsel And Chief Ethics And Compliance Officer Consulting ServicesYvm Consulting Llc May 2022 - PresentContinuus Pharmaceuticals General Counsel (part time, remote) (May 2022 to present) Manage all legal matters for integrated continuous manufacturer of pharmaceuticals • Manage regulatory and real estate development issues related to the building of a pharmaceutical manufacturing plant.Rite Aid Corporation Chief Ethics & Compliance Officer, Interim (remote) (December 2022 to June 2023)Retained on 6-month contract to address pressing compliance issues. Led a team of 80+ managing all compliance, internal audit, and food safety matters for $24 billion retail pharmacy and pharmacy benefits manager.• Prepared new enterprise-wide code of ethics, compliance work plan, and gift policy.
-
Partner1867 Partners Llc Mar 2022 - Nov 2022Formed and led team of executives attempting to purchase $250 million specialty generic and API manufacturer.
-
Vice President And General Counsel, Specialty GenericsMallinckrodt Pharmaceuticals 2018 - Jan 2022Dublin, Ireland, IeGeneral Counsel and Leadership Team member for $720 million specialty generic and active pharmaceutical ingredient manufacturer. Led a team of 260 legal, compliance, quality and government affairs professionals.• Played instrumental role in executive team that achieved revenue growth and increased profitability, following multiple quarterly losses by strategically recapturing market share, optimizing pricing and enhancing API output. • Grew revenue +3% from -17% the previous fiscal year • Increased operating income to +21% versus -66%• In fewer than 5 months, prepared specialty generics business to be publicly traded • Built standalone legal, compliance, corporate secretary and government affairs functions • Created and delivered presentations to build confidence in leadership team and orient and background incoming board of directors Litigation Management:• Won the support of 50 State and Territory Attorneys General for the resolution of company’s alleged opioid liability through our consistent leadership in compliance • Resolved all outstanding opioid claims by successfully negotiating a full and final release through Chapter 11 process • Efficiently managed more than 3,000 cases by leading a team of over 120 law firm professionals at a fraction of the cost incurred by other defendants Government Affairs:• Negotiated acceptable terms of Operating Injunction with State Attorneys General that allowed successful operation of opioid business to continue post-settlement • Positioned company before Congress and the White House as the leading option for potential receipt of significant funding to increase domestic API manufacturing after establishing the first API manufacturing innovation center in collaboration with community and academic leaders • Served as subject matter expert in multiple meetings with congressional staffers and State Attorneys General to advocate on behalf of the Company -
Vice President – Legal | Litigation Management | Regulatory | Compliance | Legal OperationsMallinckrodt Pharmaceuticals 2016 - 2018Dublin, Ireland, IeManaged legal operations, government investigations, DEA compliance functions, and all major litigation. Led a team of 32 professionals and managed a budget of $70 million. Legal Strategy: • Advised and updated Board of Directors, CEO, CFO, General Counsel and Executive Committee on risks and opportunities impacting strategic plan of business • Presented to potential buyers of businesses and negotiated key provisions of acquisition and divestiture agreements Managed government investigations and litigation: • Successfully resolved FTC antitrust investigation involving acquisition of rights to a biopharmaceutical product • Successfully resolved DEA investigation involving allegations related to suspicious order monitoring and DEA inspection of manufacturing facility Compliance:• Advised hospital and autoimmune and rare disease businesses extensively on matters of compliance, including organization of sales force and agreements with specialty pharmacies Legal Operations:• Reduced outside legal spend 35% while maintaining quality of service after negotiating alternative fee arrangements with national and regional law firms
-
Associate General Counsel - Litigation Management And Controlled Substances ComplianceMallinckrodt Pharmaceuticals 2011 - 2016Dublin, Ireland, IeLed a team nine (9) professionals responsible for establishing strategy for and managed all major pieces of litigation and a budget of $15 million for $2.3 billion specialty biopharmaceutical company. Regulatory: • Designed major enhancements to DEA compliance function, including groundbreaking improvements to suspicious order monitoring and audit preparedness at five (5) facilities • Founded consortium of leading pharmaceutical manufacturers and distributors addressing prescription drug diversion and abuse through collaboration with government, industry, and medical community stakeholders • Avoided significant portfolio risk and secured opportunity for manufacturing efficiency by leading cross-functional team that demonstrated acceptable impurities levels to FDALitigation: • Initiated and resolved numerous Hatch-Waxman litigation matters involving tablet, injectable and topical products
-
Associate General Counsel – Generics | Division Counsel | Senior Counsel | CommercialCovidien /Tyco International 1999 - 2011Lead commercial attorney for seventh largest generic pharmaceutical manufacturer, Division Counsel for $300 million lab chemical and microelectronics business segment and managed large docket of commercial and product liability litigation. • Settled Hatch-Waxman patent litigation related to pharmaceutical product with $3 billion market • Drafted and negotiated agreements for the multi-million-dollar purchase of five (5) dosage pharmaceutical products and the sales of $280 million lab chemical and microelectronics business and $90 million medical gas business
-
AssociateBryan Cave Llp 1997 - 1999Denver, C0, Us -
AssociateHusch Blackwell 1994 - 199720+ U.S. Offices, Us
Donald Lohman Education Details
-
Notre Dame Law SchoolJuris Doctorate -
Quincy UniversityPolitical Science And Government
Frequently Asked Questions about Donald Lohman
What company does Donald Lohman work for?
Donald Lohman works for Api Innovation Center
What is Donald Lohman's role at the current company?
Donald Lohman's current role is Chief Legal Officer | Chief Administrative Officer | Corporate Governance | Strategy | Government Affairs | Business Development | Regulatory | Litigation | Compliance | Communications.
What schools did Donald Lohman attend?
Donald Lohman attended Notre Dame Law School, Quincy University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial